Indication
Hepatitis A
7 clinical trials
14 products
Product
Boryung Hepatitis A VaccineProduct
HAVRIX 720 JuniorClinical trial
A Randomized, Double-blind, Multicenter, Multinational, Active-controlled, Parallel-designed Phase 3 Clinical Trial to Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in Healthy Children Aged From 24months to 15yrsStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
HealiveClinical trial
The Immunogenicity and Safety of Different Vaccination Interval of Inactivated Hepatitis A Vaccine in People Aged 18-50 Years, a Phase IV Clinical TrialStatus: Active (not recruiting), Estimated PCD: 2024-03-17
Clinical trial
Phase 4 Clinical Trial to Assess the Safety, Immunogenicity,Three-year Immune Persistence of Inactivated Hepatitis A Vaccine (HAV) and Live Attenuated HAV VaccineStatus: Completed, Estimated PCD: 2015-12-01
Product
Attenuated HAV VaccineClinical trial
Hepatitis B in Cystic Fibrosis and Latent Tuberculosis RespectivelyStatus: Withdrawn, Estimated PCD: 2023-12-01
Clinical trial
Open Label Study to Assess the ~32-Year Persistence of Hepatitis A Antibody Among Participants in the Pivotal, Double-Blind, Placebo-Controlled Efficacy Study of VAQTA (Study 023-001)Status: Not yet recruiting, Estimated PCD: 2025-03-01
Product
Hepatitis A VaccineClinical trial
Comparison of Immunogenicity and Safety of Inactivated and Live-attenuated Hepatitis A Virus Vaccine Among Thai Healthy Children and Adolescents: A Randomized, Active-controlled, Open-label, Non-inferiority TrialStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
Mevac-AProduct
Havrix 720 JuniorClinical trial
Phase IV Study of Evaluating Immunogenicity and Safety of Concomitant Administration of Sabin-strain-based Inactivated Poliovirus Vaccine (Vero Cells) and Freeze-dried Live-attenuated Hepatitis A Vaccine or Inactivated Hepatitis A VaccineStatus: Not yet recruiting, Estimated PCD: 2026-08-15
Product
sIPVProduct
HepA-LProduct
HepA-I